Pillstats
Rx only · Injection, Solution · Subcutaneous

Interferon Beta-1a

Brands: Rebif · Rebif Rebidose · Interferon Beta-1a

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US4 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers1 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$531.67$1063.33$1595.00$2126.67Jan 2025Jan 2026Jan 2026
$1849.278
Latest avg · Jan 3, 2026
+4%
Since Jan 29, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
EMD Serono, Inc.unknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.